Untreated Follicular Lymphoma
Oncology·MeSH: Lymphoma, Follicular
Prevalence
56.0 / 100K
Incidence
19.6 / 100K/yr
6 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| brilinta | ASTRAZENECA PLC (AZN) |
Compare drugs
Frequently asked questions
How many drugs are in development for Untreated Follicular Lymphoma?
BioSniper tracks 6 drugs in development for Untreated Follicular Lymphoma across 2 companies.
How many clinical trials target Untreated Follicular Lymphoma?
There are 1 clinical trial targeting Untreated Follicular Lymphoma tracked by BioSniper.
What is the prevalence of Untreated Follicular Lymphoma?
The estimated prevalence of Untreated Follicular Lymphoma is approximately 56.0 per 100,000 population.
Deep-dive into Untreated Follicular Lymphoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis